---
$id: https://graph.org.ai/products/commodity/51142014
$type: Product
source: UNSPSC
code: "51142014"
title: "Sodium thiosalicylate"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sodium thiosalicylate

**UNSPSC Code**: 51142014
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C7H5O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2D9ITW04B, chemically known as 2-mercapto-benzoic acid, monosodium salt but generally known as sodium thiosalicylate, which bears US NIH Compound Identifier 8636. European Medicines Agency schedules Sodium thiosalicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15331MIG. As of Q4 2014, SODIUM THIOSALICYLATE remains the US FDA Preferred Term for this commodity. Sodium thiosalicylate bears US NLM identifiers UMLS ID C0304347 and NCI Concept Code C87326. SMILES: SC1C(CCCC1)C(=O)O.[NA].

